Private Advisory Group LLC Buys 2,727 Shares of Astera Labs, Inc. $ALAB

Private Advisory Group LLC purchased a new stake in shares of Astera Labs, Inc. (NASDAQ:ALAB – Free Report) in the third quarter, according to its most recent 13F filing with the SEC. The fund purchased 2,727 shares of the company’s stock, valued at approximately $971,000.

Several other institutional investors have also recently made changes to their positions in ALAB. Keating Financial Advisory Services Inc. purchased a new stake in shares of Astera Labs in the second quarter worth $25,000. Archer Investment Corp purchased a new position in Astera Labs during the second quarter worth about $30,000. Transamerica Financial Advisors LLC purchased a new position in Astera Labs during the second quarter worth about $35,000. Continuum Advisory LLC purchased a new position in Astera Labs during the second quarter worth about $37,000. Finally, GK Wealth Management LLC bought a new position in Astera Labs in the 3rd quarter worth about $29,000. Institutional investors own 60.47% of the company’s stock.

Analyst Upgrades and Downgrades

ALAB has been the topic of several recent analyst reports. TD Cowen lowered their price target on Astera Labs from $300.00 to $225.00 and set a “hold” rating on the stock in a report on Wednesday, November 4th. Needham & Company LLC cut their price objective on Astera Labs from $425.00 to $300.00 and set a “buy” rating for the company in a report on Wednesday, November 4th. Wall Street Zen upgraded shares of Astera Labs from a “hold” rating to a “buy” rating in a research report on Saturday, November 7th. Morgan Stanley upped their price objective on shares of Astera Labs from $382.00 to $389.00 and gave the stock an “overweight” rating in a research report on Wednesday, November 4th. Finally, BMO Capital Markets initiated coverage on shares of Astera Labs in a research note on Thursday, November 5th. They issued an “outperform” rating and a $375.00 target price on the stock. Thirteen analysts have rated the stock with a Buy rating and ten have assigned a Hold rating to the company. According to MarketBeat, Astera Labs has an average rating of “Moderate Buy” and a consensus price target of $320.85.

Get Our Latest Research Report on Astera Labs

Astera Labs Stock Performance

Shares of NASDAQ:ALAB opened at $221.83 on Monday. Astera Labs, Inc. has a 52-week low of $97.89 and a 52-week high of $499.48. The firm has a fifty day moving average of $294.27 and a 200 day moving average of $257.09. The firm has a market capitalization of $38.77 billion, a PE ratio of 88.38 and a beta of 3.86.

Astera Labs (NASDAQ:ALAB – Get Free Report) last released its earnings results on Tuesday, November 3rd. The company reported $1.32 EPS for the quarter, beating analysts’ consensus estimates of $1.19 by $0.13. Astera Labs had a return on equity of 25.35% and a net margin of 29.64%. The business had revenue of $584.90 million for the quarter, compared to analysts’ expectations of $550.78 million. During the same quarter in the prior year, the firm earned $0.49 earnings per share. The firm’s revenue was up 153.6% on a year-over-year basis. On average, sell-side analysts forecast that Astera Labs, Inc. will post 2.99 EPS for the current fiscal year.

Insider Activity

In other news, Director Stefan A. Dyckerhoff sold 8,994 shares of the stock in a transaction dated Thursday, November 5th. The stock was sold at an average price of $211.41, for a total transaction of $1,901,421.54. Following the transaction, the director directly owned 1,987 shares in the company, valued at approximately $420,071.67. This represents a 81.91% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Manuel Alba sold 183,000 shares of the firm’s stock in a transaction dated Tuesday, September 1st. The shares were sold at an average price of $280.13, for a total value of $51,263,790.00. Following the transaction, the director directly owned 253,863 shares in the company, valued at approximately $71,114,642.19. This represents a 41.89% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last ninety days, insiders have sold 220,497 shares of company stock valued at $62,043,303. Corporate insiders own 10.40% of the company’s stock.

About Astera Labs

(Free Report)

Astera Labs, Inc. is a fabless semiconductor company that develops connectivity solutions for cloud and artificial intelligence infrastructure. Its products are designed to help move data among processors, accelerators, memory and other components in high-performance computing systems. The company’s portfolio includes Aries PCIe and CXL retimers, Taurus Ethernet smart cable modules, Scorpio fabric switches and Leo CXL memory connectivity controllers. Astera Labs also offers software tools to help customers configure and monitor its connectivity products.

See Also

Want to see what other hedge funds are holding ALAB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Astera Labs, Inc. (NASDAQ:ALAB – Free Report).

Institutional Ownership by Quarter for Astera Labs (NASDAQ:ALAB)

Receive News & Ratings for Astera Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astera Labs and related companies with MarketBeat.com's FREE daily email newsletter.